Advertisement Acacia's subsidiary signs licensing agreement with Edwards Lifesciences - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Acacia’s subsidiary signs licensing agreement with Edwards Lifesciences

Acacia Research, a developer and licensor of patented technologies, has announced that its Cardio Access subsidiary has entered into a licensing agreement with Edwards Lifesciences, a provider of heart valves and hemodynamic monitoring devices, covering a patent relating to certain medical devices.

The technology generally relates to devices known as cannulae having multiple access port legs and at least one hemostatic valve which are adapted for insertion of various catheters into the body.

The agreement resolves litigation pending in the US District Court for the Eastern District of Texas with respect to certain Edwards’s products.